Core B - Translational regulation and medicinal Chemistry
$212,155P01FY2016HLNIH
Case Western Reserve University, Cleveland OH
Investigators
Linked publications & trials
Paper 38318660Paper 37741264Paper 37253609Paper 36288700Paper 35931084Paper 35871974Paper 35785452Paper 35512801Paper 35209089Paper 35120338Paper 35051411Paper 34914637Paper 34852941Paper 34790976Paper 34679661Paper 34326365Paper 33844005Paper 33780653Paper 33779531Paper 33573995Paper 33465316Paper 33434409Paper 33115334Paper 32962996Paper 32790645Paper 32682670Paper 32597195Paper 32531116Paper 32522463Paper 32490751Paper 32164188Paper 31932420Paper 31682530Paper 31596601Paper 31590598Paper 31233696Paper 31209076Paper 31126900Paper 31116581Paper 30811946Paper 30794773Paper 30538128Paper 30487609Paper 30348763Paper 29798895Paper 29581312Paper 29298528
Abstract
Core B. Translational Regulatory Affairs and Medicinal Chemistry Project Abstract The Translational Regulatory Affairs and Medicinal Chemistry Core will serve as an essential resource for the project teams by creating a consolidated process for the preparation and submission of documents for regulatory review by local, state, and federal agencies; by expediting the approval of new clinical modalities; by providing guidance and referral on aspects of clinical chemistry and cGMP; by facilitating industry and institutional interactions; and by insuring the inventor(s)'s and institution's interests in novel discoveries are protected.
View original record on NIH RePORTER →